Friday, 03 July 2020
New York
First Human Trial of Potential COVID-19 Vaccine Underway in Australia
Wednesday, 27 May 2020 17:52 WIB | GLOBAL |Global

The southern hemisphere's first human trials of a potential coronavirus vaccine have started in Australia.  131 people aged between 18-59 are involved in the program in Melbourne and Brisbane.          

The potential vaccine, NVX-CoV2373, is being developed by the American biotech company Novavax. It started working on the drug in January when the COVID-19 outbreak began in China. It aims to boost the body's immune response and stimulate high levels of neutralizing antibodies. 

If the vaccine works, researchers hope 100 million doses can be made by the end of this year and 1.5 billion next year.

Researchers say that "vaccines are miracles and have a great way of protecting populations against these severe diseases."

Dr Paul Griffin is an infectious diseases expert who is involved in the Australian COVID 19 trial.  He hopes the drug will successfully attack the virus and be ready for use within months.  

"We look for antibodies and the type and number of antibodies, and then we take some things out of the subjects through those blood tests and do a lot of laboratory experiments to show that it neutralizes the virus.  The company manufacturing the vaccine have already started that scaling-up process, so they are already making a lot of doses of this vaccine.  So if we can prove it is safe and effective then, potentially, by the end of the year there will be significant number of doses available," Griffin said. 

Australian authorities say the trial is a significant step forward in the global race for a coronavirus vaccine.  Some participants will receive a placebo while others will be administered Novavax's drug.

Early results are expected in July, and scientists expect "some conclusive results by the end of this year".  Phase two trials would take place with thousands of volunteers in several countries.  Volunteers are still needed, and the research team has stressed that no live coronavirus is used in experiments on people.

Novavax has received $388 million from the Norway-based Coalition for Epidemic Preparedness Innovations.  There are more than 100 potential coronavirus vaccines in development, and about a dozen have made it to the human trial stage.  

It is a global race potentially worth billions of dollars to those who can find a safe and reliable treatment for a virus that has killed almost 350,000 people around the world.

Source : VOA

Russian Voters Clear Path for Putin to Remain in Power Until 2036...
Thursday, 2 July 2020 23:21 WIB

Voters in Russia have approved a package of constitutional reforms that includes opening the possibility that President Vladimir Putin can remain president until 2036.¯ Kremlin spokesman Dmitry Pes...

US, German Firms Say Possible COVID Vaccine Shows Encouraging Results...
Thursday, 2 July 2020 17:43 WIB

Tests of a possible COVID-19 vaccine are showing encouraging results, U.S. and German scientists say. U.S.-based Pfizer and the German firm BioNTech have teamed up for what they call Project Lightspe...

Pompeo Calls China Hong Kong Security Law an Affront...
Thursday, 2 July 2020 11:12 WIB

U.S. Secretary of State Mike Pompeo said Wednesday that China™s newly enacted Hong Kong national security law was œan affront to all nations and that Washington was taking steps to end special ...

US Sets New Single-Day Record for Coronavirus Infections...
Wednesday, 1 July 2020 23:18 WIB

The United States marked another grim milestone Tuesday as it posted a record  47,000 new COVID-19 cases, the biggest one day increase in new infections since the start of the pandemic.  Th...

Pompeo Urges Accountability for Iran via Arms Embargo...
Wednesday, 1 July 2020 16:33 WIB

U.S. Secretary of State Mike Pompeo urged the U.N. Security Council on Tuesday to "hold Iran accountable and extend an arms embargo due to expire in October. "Renewing the embargo will exert more ...

Nasdaq Closes at Record For Second Straight Session Ahead of July 4th Holiday

U.S. stocks clung to their gains at the end of Thursday after a stronger-than-expected employment report confirmed the labor market's rapid recovery at the end of the second-quarter. Wall Street will be shuttered on Friday in honor of the...

Hong Kong stocks post strong gains (Review)

Hong Kong stocks soared Thursday, in line with a global advance on hopes for a virus vaccine and despite concerns over a draconian security law imposed on the city by Beijing that raised questions about its future as a business hub. The Hang Seng...

Oil futures end higher, with U.S. prices at their highest since March

Oil futures settled higher on Thursday, buoyed by a hefty decline in last week's U.S. crude supplies and better-than-expected domestic jobs growth in June. August West Texas Intermediate oil rose 83 cents, or 2.1%, to settle at $40.65 a barrel on...

July, Gold is Still Promising
Wednesday, 1 July 2020 16:41 WIB

Index futures closed above $ 1,800 per ounce on Tuesday, June 30, 2020, which also means closing in the first half of this year. Over the past six...

Gold futures end lower a day after highest finish since 2011
Thursday, 2 July 2020 01:28 WIB

Gold futures pulled back Wednesday, after settling a day earlier at their highest since 2011. "Gold remains in an uptrend but some fatigue may be...

Gold prices retreat to start July after the notching their highest finish since 2011
Wednesday, 1 July 2020 18:58 WIB

Gold futures were drifting lower Wednesday after topping $1,800 and marking the highest finish since in about nine years Tuesday, as uncertainty...

Gold Holds Drop on Vaccine Developments, Factory Data
Thursday, 2 July 2020 11:23 WIB

Gold held a decline after positive coronavirus vaccine developments and better-than-expected U.S. manufacturing data lifted sentiment and...